bioMérieux to Acquire BioFire
The two companies present powerful strategic synergies.
Read MorePosted by Judy O'Rourke | Sep 3, 2013 | Molecular Diagnostics |
The two companies present powerful strategic synergies.
Read MorePosted by Judy O'Rourke | Aug 22, 2013 | Cancer, Miscellaneous, Research |
NIH-Funded Study Provides More Evidence Supporting Development of Noninvasive Tests
Read MorePosted by Judy O'Rourke | Jul 23, 2013 | Molecular Diagnostics |
The company’s clinical services lab uses next-generation DNA and genetic analysis technologies that include multiplex real-time PCR, whole genome mapping, and next-generation sequencing.
Read MorePosted by Clinical Lab Products | Jul 8, 2013 | Miscellaneous, Research |
An NIH-sponsored research project has yielded a test that can diagnose kidney transplant rejection. The group found three biomarkers that together indicate the status of the kidney and can even predict future rejection.
Read MorePosted by Judy O'Rourke | Jun 27, 2013 | Miscellaneous |
Initial results of priority actions to fight against antimicrobial resistance, determined at the event, are expected within 18 months.
Read More